MannKind Corporation MNKD

US Biotechnology

$4.16 ▼ -0.72% ($-0.03)

Open $4.18

Prev Close $4.19

Day Range $4.07 – $4.25

52W Range $2.23 – $6.51

Market Cap $1.35B

P/E (TTM) 229.86

Beta 1.12

EPS (TTM) $-0.14

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2004-07-28
Shares Out.	321,540,000
Website	mannkindcorp.com/ ↗
Phone	18009279800
Employees	592
Revenue	$101.9M
Gross Profit	$78.4M
Net Income	-$23.2M
Free Cash Flow	-$78.4M
Total Assets	$722.6M
Total Liabilities	$759.9M
Equity	-$37.3M

About MannKind Corporation

MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

MannKind Corporation is a publicly traded company under the ticker symbol MNKD on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.